Heidelberg Symphony Orchestra

For the production of Leberzellsuspension, vital human liver cells from non-transplantable donor livers are isolated and then processed to a drug. To do this, Cytonet has developed proprietary, optimized process. This procedure guarantees Cytonet standardized liver cells from consistently high quality that meet all safety aspects. Also, Cytonet can draw on many years of experience in the production of high-quality blood stem cells during the extraction and preparation of liver cells. Incyte contains valuable tech resources. The liver cells are Cryopreserved at below-150. They are durable and available at any time after a brief thaw process for over 10 years. Cytonet’s goal in the future more severe, life-threatening metabolic disorders by the To be able to use of human cells heal.

All biotechnological laboratories by Cytonet meet by the regulatory authorities in Europe and the United States of required international standards. Many years of experience in the work according to GMP guidelines for quality assurance of the production process guarantees a high quality and product safety. The magnolia gmbh advertising agency was founded in 2002. You has ten employees and has its headquarters in Mannheim, Germany. In addition to major customers such as ABB, Bauer fruit juices, CinemaxX, Dorint, G + H, graeff halls – and container construction, Granini or Golden toast know the owner-operated full-service agency of numerous regional customers in Mannheim and the surrounding area such as aquadrom Hockenheim, BMW-Mannheim, Cineplex-Mannheim, Heidelberg Symphony Orchestra, metropolitan region Rhein-Neckar, city of Heidelberg or Weldebrau. Contact: magnolia gmbh advertising agency, Matthias Ries, 30 Forest Park Road, 68163 Mannheim, Tel: 0621 / 83-323-600, press contact: magnolia gmbh advertising agency Matthias Ries Forest Park Road 30 68163 Mannheim Tel: 0621 / 83 323-600 fax: 0621 / 83 323-625

Magnolia

The Cytonet group is active in the field of medical biotechnology Mannheim, March 24, 2010. The Cytonet group is active in the field of medical biotechnology and new customer of the Mannheim agency magnolia. The agency designed a new claim for Cytonet first, developed a brochure and a presentation. Cytonet in the cell therapy is already the largest companies of in Germany. The company develops, produces and markets new, cell-based medical products.

Cytonet partners are internationally leading university hospitals. Whose research is transmitted in their own procedural approaches and promising technologies to develop pioneering products. The Mannheim full service agency could convince through their work and as a new customer win Cytonet. In addition to daily work, the Agency was charged with the conception of a new claims which makes clear the positioning on the market and the positioning within the industry. As more projects get Development of a brochure as well as a fair map. Cytonet to increasingly as a first mover\”in the medically focused biotechnology cell research are perceived. The Cytonet is group as spin-off of the cell therapy Division of the Roche Diagnostics company founded and established himself as Germany’s leader in cell therapy with headquarters in Weinheim. Production sites are located in Heidelberg, Hanover and Durham (NC, United States).

Dietmar Hopp, co-founder of SAP, invested in Cytonet. Today are Dietmar Hopp and his family’s majority shareholder. About Cytonet: The Cytonet group is active in the field of medical biotechnology. Cytonet in the cell therapy is already the largest companies of in Germany. The company develops, produces and markets new, cell-based medical products. Cytonet partners are internationally leading university hospitals. Their research will be transmitted in their own procedural approaches and promising technologies to this groundbreaking Products to develop. The company is focused on developments that offer new therapies for life-threatening liver disease. Currently, a clinical study investigates the effect of Leberzelltherapie with congenital metabolic disorders of the urea cycle in newborns.